Research programme: anti-EGFR monoclonal antibodies - InNexus BiotechnologyAlternative Names: DXL 1218
Latest Information Update: 16 Jul 2016
At a glance
- Originator InNexus Biotechnology
- Class Monoclonal antibodies
- Mechanism of Action Epidermal growth factor receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Colorectal-cancer in Canada (Parenteral)
- 11 Nov 2008 Preclinical trials in Colorectal cancer in Canada (Parenteral)